Approval · Notice of Compliance 2476 · 2001
BIONEFAZODONE: Notice of Compliance 2476
Issued April 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2476
- Date
- April 30, 2001
- Company
- Bioenhance Medicines Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIONEFAZODONE | 02243791 | — |
| BIONEFAZODONE | 02243792 | — |
| BIONEFAZODONE | 02243793 | — |
| BIONEFAZODONE | 02243794 | — |
| BIONEFAZODONE | 02243795 | — |
Medicinal ingredients
- NEFAZODONE HCL 50 MG per TAB
- NEFAZODONE HCL 100 MG per TAB
- NEFAZODONE HCL 150 MG per TAB
- NEFAZODONE HCL 200 MG per TAB
- NEFAZODONE HCL 300 MG per TAB